Family Care International, NY, USA.
Int J Gynaecol Obstet. 2013 Oct;123(1):4-6. doi: 10.1016/j.ijgo.2013.04.019. Epub 2013 Jul 13.
Emergency contraception has been known for several decades, and dedicated products have been on the market for close to 20 years. Yet it is unclear whether women, particularly in low-resource countries, have access to this important second-chance method of contraception.
To review relevant policies, regulations, and other factors related to access to emergency contraception worldwide.
A wide range of gray literature was reviewed, several specific studies were commissioned, and a number of online databases were searched.
Several positive policies and regulations are in place: emergency contraception products are registered in the majority of countries around the world, listed in many countries' essential medicines lists, included in widely used guidance, and supported by most donors. Yet analysis of demographic data shows that the majority of women in low-income countries have never heard of emergency contraception, and surveys find that many providers have negative attitudes toward providing emergency contraception.
Despite more than a decade of concerted international and country-level efforts to ensure that women have access to emergency contraception, accessibility remains limited.
紧急避孕法问世已有数十年，专门的产品也已上市近 20 年。但目前尚不清楚妇女，特别是资源匮乏国家的妇女是否能够获得这种重要的事后避孕方法。
审查全球范围内与获取紧急避孕措施相关的政策、法规和其他因素。
审查了大量灰色文献，委托进行了几项具体研究，并搜索了多个在线数据库。
目前有一些积极的政策和法规：在世界上大多数国家，紧急避孕产品都已注册，在许多国家的基本药物清单中都有列出，被广泛使用的指南所收录，并得到了大多数捐助者的支持。然而，对人口统计数据的分析表明，低收入国家的大多数妇女从未听说过紧急避孕，调查发现许多提供者对提供紧急避孕持消极态度。
尽管十多年来，国际和国家各级都在努力确保妇女能够获得紧急避孕措施，但获得途径仍然有限。
